Clinical trial
Treatment of Mature B-cell Lymphoma/Leukaemia
NCT00162656 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00162656 |
|---|---|
| Title | Treatment of Mature B-cell Lymphoma/Leukaemia |
| Official title | Treatment of Mature B-cell Lymphoma/Leukaemia A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | B-Cell Lymphoma |
| Intervention type | Drug |
| Interventions | half cyclophosphamide, without COPADM3, mini CYVE, without 3 maintenance courses, LMB B, LMB C |
| Enrollment | 848 |
| Start date | May 1, 1996 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2011 |
| First posted | Sep 13, 2005 |
| Last update posted | Mar 28, 2012 |
| Countries | France, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: